Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.
2.

Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation.

Miralem T, Lerner-Marmarosh N, Gibbs PE, Jenkins JL, Heimiller C, Maines MD.

FASEB J. 2016 Aug;30(8):2926-44. doi: 10.1096/fj.201600330RR. Epub 2016 May 10.

3.

Biliverdin reductase: a target for cancer therapy?

Gibbs PE, Miralem T, Maines MD.

Front Pharmacol. 2015 Jun 3;6:119. doi: 10.3389/fphar.2015.00119. eCollection 2015. Review.

4.

Renal capsule xenografting and subcutaneous pellet implantation for the evaluation of prostate carcinogenesis and benign prostatic hyperplasia.

Nicholson TM, Uchtmann KS, Valdez CD, Theberge AB, Miralem T, Ricke WA.

J Vis Exp. 2013 Aug 28;(78). doi: 10.3791/50574.

5.

The human biliverdin reductase-based peptide fragments and biliverdin regulate protein kinase Cδ activity: the peptides are inhibitors or substrate for the protein kinase C.

Miralem T, Lerner-Marmarosh N, Gibbs PE, Tudor C, Hagen FK, Maines MD.

J Biol Chem. 2012 Jul 13;287(29):24698-712. doi: 10.1074/jbc.M111.326504. Epub 2012 May 14.

6.
7.
8.

Human biliverdin reductase suppresses Goodpasture antigen-binding protein (GPBP) kinase activity: the reductase regulates tumor necrosis factor-alpha-NF-kappaB-dependent GPBP expression.

Miralem T, Gibbs PE, Revert F, Saus J, Maines MD.

J Biol Chem. 2010 Apr 23;285(17):12551-8. doi: 10.1074/jbc.M109.032771. Epub 2010 Feb 22.

9.

Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.

Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD.

Proc Natl Acad Sci U S A. 2008 May 13;105(19):6870-5. doi: 10.1073/pnas.0800750105. Epub 2008 May 7.

10.

Regulation of TNF-alpha-activated PKC-zeta signaling by the human biliverdin reductase: identification of activating and inhibitory domains of the reductase.

Lerner-Marmarosh N, Miralem T, Gibbs PE, Maines MD.

FASEB J. 2007 Dec;21(14):3949-62. Epub 2007 Jul 17.

PMID:
17639074
11.

Human biliverdin reductase, a previously unknown activator of protein kinase C betaII.

Maines MD, Miralem T, Lerner-Marmarosh N, Shen J, Gibbs PE.

J Biol Chem. 2007 Mar 16;282(11):8110-22. Epub 2007 Jan 16.

13.

Biliverdin reductase, a novel regulator for induction of activating transcription factor-2 and heme oxygenase-1.

Kravets A, Hu Z, Miralem T, Torno MD, Maines MD.

J Biol Chem. 2004 May 7;279(19):19916-23. Epub 2004 Feb 25.

15.
16.

Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells.

Price DJ, Miralem T, Jiang S, Steinberg R, Avraham H.

Cell Growth Differ. 2001 Mar;12(3):129-35.

17.

Heparan sulfate chains with antimitogenic properties arise from mesangial cell-surface proteoglycans.

Wang A, Miralem T, Templeton DM.

Metabolism. 1999 Oct;48(10):1220-9.

PMID:
10535382
18.

Inactivation of kinase cascades in mesangial cells grown on collagen type I.

Miralem T, Templeton DM.

Am J Physiol. 1998 Oct;275(4):F585-94. doi: 10.1152/ajprenal.1998.275.4.F585.

PMID:
9755130
19.

Cadmium and calcium-dependent c-fos expression in mesangial cells.

Templeton DM, Wang Z, Miralem T.

Toxicol Lett. 1998 Mar 16;95(1):1-8.

PMID:
9650640
20.
21.

Chelation of intracellular calcium prevents mesangial cell proliferative responsiveness.

Whiteside C, Munk S, Zhou X, Miralem T, Templeton DM.

J Am Soc Nephrol. 1998 Jan;9(1):14-25.

22.

Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells.

Miralem T, Wang A, Whiteside CI, Templeton DM.

J Biol Chem. 1996 Jul 19;271(29):17100-6.

23.

Collagen type I enhances endothelin-mediated contraction and induces nonproliferating phenotype in mesangial cells.

Miralem T, Whiteside CI, Templeton DM.

Am J Physiol. 1996 Jun;270(6 Pt 2):F960-70.

PMID:
8764315
24.

Effect of aluminum chloride, -citrate, and -maltol on the calcium-mediated degradation of neurofilament proteins.

Van Ginkel MF, Heijink E, Dekker PB, Miralem T, van der Voet GB, de Wolff FA.

Neurotoxicology. 1993 Spring;14(1):13-8.

PMID:
8361672

Supplemental Content

Loading ...
Support Center